Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota

• Published in: Phytomedicine (Stuttgart) Vol. 106; p. 154401
• Main Authors: Lin, Caiji, Zeng, Zheng, Lin, Yiru, Wang, Pengfei, Cao, Danli, Xie, Kaihong, Luo, Yao, Yang, Hao, Yang, Jiaming, Wang, Wenxue, Luo, LingJie, Lin, Huihui, Chen, Hang, Zhao, Yufan, Shi, Yongwei, Gao, Zixiang, Liu, Huidi, Liu, Shu-Lin
• Format: Journal Article
• Language: English
• Published: Elsevier GmbH 01.11.2022
• Subjects: Gut microbiota; Naringenin; Ovarian cancer; PI3K; Gut microbiota; PCoA; Naringenin; IHC; p.o., per os; i.p; NMDS; PFA; EGFR; Ovarian cancer; PCA; MMP; PI3K; CCND1; CMC-Na; EOC; HE; HPLC
• ISSN: 0944-7113; 1618-095X
• DOI: 10.1016/j.phymed.2022.154401

Ovarian cancer has the highest mortality among all gynecological malignancies; currently, no effective therapeutics are available for its treatment. Naringenin has been shown to inhibit the progression of various cancers, but its inhibitory effect on ovarian cancer remains unknown. This study aimed to evaluate the inhibitory effects of naringenin on ovarian cancer and elucidate the underlying mechanisms. Cancer cell proliferation was detected by cell counting kit-8 and crystal violet assays, and the migration capability was determined by wound healing and transwell assays. Western blotting and immunohistochemistry assays were employed to determine the expression levels of the epidermal growth factor receptor, phosphatidylinositol 3-kinase (PI3K) and cyclin D1 in vitro and in vivo, respectively. An ES-2 xenograft nude mouse model was established for the in vivo experiments, and fecal samples were collected for intestinal microbiota analysis by 16S rDNA sequencing. Naringenin suppressed the proliferation and migration of A2780 and ES-2 cancer cell lines and downregulated PI3K in vitro. In animal experiments, naringenin treatment significantly decreased the tumor weight and volume, and oral administration exhibited greater effects than intraperitoneal injection. Additionally, naringenin treatment ameliorated the population composition of the microbiota in animals with ovarian cancer and significantly increased the abundances of Alistipes and Lactobacillus. Naringenin suppresses epithelial ovarian cancer by inhibiting PI3K pathway expression and ameliorating the gut microbiota, and the oral route is more effective than parenteral administration.